Skip to main content
Top

Breast Cancer

Issue 2/2013

Content (13 Articles)

Review Article

Effects of toremifene versus tamoxifen on breast cancer patients: a meta-analysis

Feng Chi, Rong Wu, Yuecan Zeng, Rui Xing, Yang Liu, Zhaoguo Xu

Review Article

The current status of positron emission mammography in breast cancer diagnosis

Vasileios Kalles, George C. Zografos, Xeni Provatopoulou, Dimitra Koulocheri, Antonia Gounaris

Original Article

Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B

Hidetoshi Hayashi, Junji Tsurutani, Taro Satoh, Norikazu Masuda, Wataru Okamoto, Ryotaro Morinaga, Masaaki Terashima, Masaki Miyazaki, Isamu Okamoto, Yukihiro Nishida, Shusei Tominaga, Yukihiko Tokunaga, Masahide Yamaguchi, Junichi Sakamoto, Takahiro Nakayama, Kazuhiko Nakagawa

Original Article

Diffusion-weighted imaging (b value = 1500 s/mm2) is useful to decrease false-positive breast cancer cases due to fibrocystic changes

Miho Ochi, Toshiro Kuroiwa, Shunya Sunami, Junji Murakami, Shinichiro Miyahara, Takashi Nagaie, Masafumi Oya, Hidetake Yabuuchi, Masamitsu Hatakenaka

Original Article

Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer

Akiko Kawano, Chikako Shimizu, Kenji Hashimoto, Takayuki Kinoshita, Hitoshi Tsuda, Hirofumi Fujii, Yasuhiro Fujiwara

Original Article

Power Doppler breast ultrasound: association of vascularization and ER/c-erbB-2 co-expression in invasive breast carcinoma

Shou-Tung Chen, Shou-Jen Kuo, Hwa-Koon Wu, Li-Sheng Chen, Dar-Ren Chen

Original Article

Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens

Mutsuko Ibusuki, Peifen Fu, Satoko Yamamoto, Saori Fujiwara, Yutaka Yamamoto, Yumi Honda, Ken-ichi Iyama, Hirotaka Iwase

Original Article

Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy

Bhumsuk Keam, Seock-Ah Im, Youngil Koh, Sae-Won Han, Do-Youn Oh, Nariya Cho, Jee Hyun Kim, Wonshik Han, Keon Wook Kang, Woo Kyung Moon, Tae-You Kim, In Ae Park, Dong-Young Noh, June-Key Chung, Yung-Jue Bang

Original Article

Serum leptin level and waist-to-hip ratio (WHR) predict the overall survival of metastatic breast cancer (MBC) patients treated with aromatase inhibitors (AIs)

Mehmet Artac, Hakan Bozcuk, Aysel Kıyıcı, Orhan Onder Eren, Melih Cem Boruban, Mustafa Ozdogan

Original Article

Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer

Yasuaki Sagara, Yasuyo Ohi, Ayami Matsukata, Daisuke Yotsumoto, Shinichi Baba, Shugo Tamada, Yoshiaki Sagara, Yoshito Matsuyama, Mitsutake Ando, Yoshiaki Rai, Yoshiatsu Sagara

Case Report

A case of tumor-forming pseudoangiomatous stromal hyperplasia of the breast

Hiroyuki Takagi, Junichi Miyairi, Motoyuki Hata, Yasusi Kirii, Shinichi Tsuchiya

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine